logo

Sesen Bio Inc (SESN)



Trade SESN now with
  Date
  Headline
5/16/2018 6:32:04 AM Eleven Biotherapeutics Changes Its Name To Sesen Bio; New Nasdaq Ticker Symbol 'SESN' Effective On May 17
4/4/2018 4:11:11 PM Eleven Biotherapeutics Q4 Loss/share $0.22 Vs. Loss $0.15 Year Ago
4/3/2018 8:34:31 AM Eleven Biotherapeutics : Preliminary Data From Phase 3 VISTA Trial In Bladder Cancer To Be Presented
3/21/2018 9:24:40 AM Eleven Biotherapeutics To Buy About 7.9 Mln Shares At $1.13/shr In Offering Priced At-the-market
3/12/2018 6:32:19 AM Eleven Biotherapeutics Completes Enrollment In VISTA Phase 3 Registration Trial Of Vicinium For NMIBC
1/24/2018 3:24:04 PM Eleven Biotherapeutics Appoints Richard Fitzgerald As CFO